Chitosan-dipotassium orthophosphate lyophilizate: a novel in situ thermogel carrier system of allogeneic platelet lysate growth factors
Open Access
- 31 January 2022
- journal article
- research article
- Published by Taylor & Francis in Drug Delivery
- Vol. 29 (1) , 413-426
Abstract
The clinical success of platelet-rich plasma (PRP) is constrained by its limited mechanical strength, rapid disintegration by lytic enzymes, and the consequent short-term release of bioactive growth factors (GFs). Recently, attempts to formulate PRP and other hemoderivatives, such as platelet lysate (PL) have been underway. The current study aimed to formulate allogeneic freeze-dried human platelet lysate (HPL) onto lyophilized chitosan - dipotassium hydrogen orthophosphate (CS/DHO) thermo-sensitive scaffolds. A systemic approach was employed to optimize freeze-drying (FD) procedures targeting predefined critical quality attributes (CQAs). Thermal behavior, vibrational spectroscopy, morphological and moisture content analyses were used to detect possible protein destabilization during formulation and suboptimal cake properties. The effect of CS/DHO concentrations on thermo-responsiveness and release kinetics were investigated. Finally, six-months stability and cytotoxicity studies were carried out. An optimized lyophilizate was attainable with residual moisture of less than 5% and thermoresponsive to 33 °C in less than 3 min. HPL proteins were sustainedly released over five days in a pH-sensitive manner. The stability study indicated plausible physical and biochemical stability. Cell viability testing supported the cytocompatibility of the system. Finally, the lyophilizate variant of CS/DHO thermogel overcomes limited storage stability previously posed as a challenge in freshly prepared thermogels. The developed system overcomes the drawbacks of currently used PRP treatment and provides a novel GF-rich scaffold for wound repair. Graphical AbstractKeywords
This publication has 60 references indexed in Scilit:
- Biological Stability of Plasma Rich in Growth Factors Eye Drops After Storage of 3 MonthsCornea, 2013
- Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factorsStem Cell Research & Therapy, 2013
- Unraveling protein stabilization mechanisms: Vitrification and water replacement in a glass transition temperature controlled systemBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2013
- Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active componentsCytotherapy, 2012
- Growth Factor and Catabolic Cytokine Concentrations Are Influenced by the Cellular Composition of Platelet-Rich PlasmaThe American Journal of Sports Medicine, 2011
- Characterizing the Freeze–Drying Behavior of Model Protein FormulationsAAPS PharmSciTech, 2010
- Preparation of Pooled Human Platelet Lysate (pHPL) as an Efficient Supplement for Animal Serum-Free Human Stem Cell CulturesJournal of Visualized Experiments, 2009
- Development of Injectable Thermogelling Chitosan–Inorganic Phosphate Solutions for Biomedical ApplicationsBiomacromolecules, 2007
- Platelet-Rich Plasma (PRP): What Is PRP and What Is Not PRP?Implant Dentistry, 2001
- Novel injectable neutral solutions of chitosan form biodegradable gels in situBiomaterials, 2000